Diabetic nephropathy (DN) is one of the most common and serious chronic complications of diabetes mellitus, however, no efficient clinical drugs exist for the treatment of DN. We selected and synthesized several sesquiterpene lactones (SLs), and then used the MTT assay to detect rat mesangial cells (MCs) proliferation, ELISA to measure the expression level of monocyte chemoattractant protein-1 (MCP-1), transforming growth factor beta (TGF-β1) and fibronectin(FN), real-time fluorescent quantitative PCR analysis to measure the MCP-1 and TGF-β1 gene expression, western blot to detect the level of IκBα protein and EMSA to measure the activation of nuclear factor kappa B (NF-κB). We discovered that SLs, including parthenolide (PTL), micheliolide (MCL), arglabin, and isoalantolactone (IAL), as well as several synthetic analogs of these molecules, could effectively attenuate the high glucose-stimulated activation of NF-κB, the degradation of IκBα, and the expression of MCP-1, TGF-β1 and FN in rat mesangial cells (MCs). These findings suggest that SLs and their derivatives have potential as candidate drugs for the treatment of DN.
糖尿病肾病(DN)是糖尿病最常见且严重的慢性并发症之一,但目前尚无有效的临床药物可用于DN的治疗。我们选择并合成了几种
倍半萜内酯(SLs),然后使用M
TT法检测大鼠系膜细胞(MCs)的增殖,采用ELI
SA法测量单核细胞趋化蛋白-1(MCP-1)、转化生长因子β(TGF-β1)和纤维连接蛋白(FN)的表达
水平,利用实时荧光定量PCR分析测定MCP-1和TGF-β1
基因表达,采用西方印迹法检测IκBα蛋白
水平,电泳迁移率实验(
EMSA)检测核因子κB(NF-κB)的活化。我们发现,
倍半萜内酯(如巴特诺里德(
PTL)、米克希而内酯(MCL)、阿尔格拉滨和异阿兰酯(IAL))及其几种合成类似物能够有效减弱高糖刺激下大鼠系膜细胞(MCs)中NF-κB的活化、IκBα的降解,以及MCP-1、TGF-β1和FN的表达。这些发现表明,
倍半萜内酯及其衍
生物具有作为DN治疗候选药物的潜力。